Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue
1.4 Market Analysis by Type
1.4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Combination Therapy
1.4.3 Monotherapy
1.5 Market by Application
1.5.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Positive Lymphoma
1.5.3 Follicular Lymphoma
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Perspective (2015-2026)
2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Growth Trends by Regions
2.2.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 BCL-2 (B-cell lymphoma 2) Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key BCL-2 (B-cell lymphoma 2) Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Market Size
3.1.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Revenue (2015-2020)
3.1.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio
3.2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2019
3.3 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players Head office and Area Served
3.4 Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
3.5 Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Type (2021-2026)
5 BCL-2 (B-cell lymphoma 2) Inhibitors Breakdown Data by Application (2015-2026)
5.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
5.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
6.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in North America (2019-2020)
6.3 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
6.4 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
7.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Europe (2019-2020)
7.3 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
7.4 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
8.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in China (2019-2020)
8.3 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
8.4 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
9.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Japan (2019-2020)
9.3 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
9.4 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
10.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
11.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in India (2019-2020)
11.3 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
11.4 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
12.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
13Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.1.4 AbbVie Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview and Its Total Revenue
13.2.3 Roche BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.2.4 Roche Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Abcam
13.3.1 Abcam Company Details
13.3.2 Abcam Business Overview and Its Total Revenue
13.3.3 Abcam BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.3.4 Abcam Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
13.3.5 Abcam Recent Development
13.4 Biorbyt
13.4.1 Biorbyt Company Details
13.4.2 Biorbyt Business Overview and Its Total Revenue
13.4.3 Biorbyt BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.4.4 Biorbyt Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
13.4.5 Biorbyt Recent Development
13.5 Biovison
13.5.1 Biovison Company Details
13.5.2 Biovison Business Overview and Its Total Revenue
13.5.3 Biovison BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.5.4 Biovison Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
13.5.5 Biovison Recent Development
13.6 Tocris Bioscience
13.6.1 Tocris Bioscience Company Details
13.6.2 Tocris Bioscience Business Overview and Its Total Revenue
13.6.3 Tocris Bioscience BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
13.6.4 Tocris Bioscience Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
13.6.5 Tocris Bioscience Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. BCL-2 (B-cell lymphoma 2) Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue
Table 3. Ranking of Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Combination Therapy
Table 6. Key Players of Monotherapy
Table 7. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2015-2020)
Table 11. Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. BCL-2 (B-cell lymphoma 2) Inhibitors Market Growth Strategy
Table 17. Main Points Interviewed from Key BCL-2 (B-cell lymphoma 2) Inhibitors Players
Table 18. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 19. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players (2015-2020)
Table 20. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2019)
Table 21. Global BCL-2 (B-cell lymphoma 2) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
Table 24. Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 27. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Type (2015-2020)
Table 28. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2021-2026)
Table 29. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Application (2015-2020)
Table 30. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 31. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Application (2021-2026)
Table 32. North America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 33. North America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 34. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 35. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 36. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 37. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 38. Europe Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 40. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 41. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 42. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 43. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 44. China Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 45. China Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 46. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 47. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 48. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 49. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 50. Japan Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 52. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 53. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 54. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 55. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 58. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 60. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 62. India Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 63. India Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 64. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 65. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 66. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 67. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 68. Central & South America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 70. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 72. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Abcam Company Details
Table 85. Abcam Business Overview
Table 86. Abcam Product
Table 87. Abcam Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 88. Abcam Recent Development
Table 89. Biorbyt Company Details
Table 90. Biorbyt Business Overview
Table 91. Biorbyt Product
Table 92. Biorbyt Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 93. Biorbyt Recent Development
Table 94. Biovison Company Details
Table 95. Biovison Business Overview
Table 96. Biovison Product
Table 97. Biovison Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 98. Biovison Recent Development
Table 99. Tocris Bioscience Company Details
Table 100. Tocris Bioscience Business Overview
Table 101. Tocris Bioscience Product
Table 102. Tocris Bioscience Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 103. Tocris Bioscience Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of FiguresFigure 1. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2020 VS 2026
Figure 5. Positive Lymphoma Case Studies
Figure 6. Follicular Lymphoma Case Studies
Figure 7. Others Case Studies
Figure 8. BCL-2 (B-cell lymphoma 2) Inhibitors Report Years Considered
Figure 9. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 11. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players in 2019
Figure 14. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2019
Figure 15. The Top 10 and 5 Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2019
Figure 16. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 27. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abcam Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 29. Biorbyt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biorbyt Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 31. Biovison Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biovison Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 33. Tocris Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Tocris Bioscience Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed